Webinar

TruSpine Technologies PLC
07 April 2025
 

7 April 2025

TruSpine Technologies plc

("TruSpine" or the "Company")

 

Webinar

 

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, is pleased to announce a live Webinar hosted by Geoff Miller, CEO of the Company, via the Company's recently updated Investor website on Friday, 11 April 2025, at 10:00 AM BST.

This session is open to all existing and prospective shareholders.

Questions can be submitted in advance via the webinar page until Wednesday, 9 April 2025 at 10:00 AM BST, or asked live during the event.

 

Register for free here at the link below.

https://truspinetech.com/webinars/Ve95oe-2024-agm-webinar?roomCode=icn-ikdk-gve

 

The Directors of the Company are responsible for the release of this announcement.

 

-END-

TruSpine Investor Hub 

https://investorhub.truspinetech.com

TruSpine Technologies Plc

Tel: +44 (0)20 7118 0852

Geoff Miller, Non-executive Chairman




Peterhouse Capital Limited (Broker & Financial Adviser)

 Tel: +44 (0)20 7469 0930

Lucy Williams / Duncan Vasey

 


Novus Communications (PR and IR)

Tel: +44 (0)1273 704 473

Alan Green / Jacqueline Briscoe

novuscomms@truspinetech.com

 

 

 

This communication is a "Reach" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings